Literature DB >> 9126840

Guanidinobenzoic acid inhibitors of influenza virus neuraminidase.

E A Sudbeck1, M J Jedrzejas, S Singh, W J Brouillette, G M Air, W G Laver, Y S Babu, S Bantia, P Chand, N Chu, J A Montgomery, D A Walsh, M Luo.   

Abstract

The active site of influenza virus neuraminidase (NA) is formed by 11 universally conserved residues. A guanidino group incorporated into two unrelated NA inhibitors was previously reported to occupy different negatively charged sites in the NA active site, A new inhibitor containing two guanidino groups was synthesized in order to utilize both sites in an attempt to acquire a combined increase in affinity. The X-ray crystal structures of the complexes show that the expected increase in affinity could not be achieved even though the added guanidino group binds to the negatively charged site as designed. This suggests that the ligand affinity to the target protein is contributed both from ligand-protein interactions and solvation/conformation energy of the ligand.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9126840     DOI: 10.1006/jmbi.1996.0885

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  5 in total

1.  Analysis of inhibitor binding in influenza virus neuraminidase.

Authors:  B J Smith; P M Colman; M Von Itzstein; B Danylec; J N Varghese
Journal:  Protein Sci       Date:  2001-04       Impact factor: 6.725

Review 2.  Pneumococcal virulence factors: structure and function.

Authors:  M J Jedrzejas
Journal:  Microbiol Mol Biol Rev       Date:  2001-06       Impact factor: 11.056

3.  Combining crystallographic information and an aspherical-atom data bank in the evaluation of the electrostatic interaction energy in an enzyme-substrate complex: influenza neuraminidase inhibition.

Authors:  Paulina M Dominiak; Anatoliy Volkov; Adam P Dominiak; Katarzyna N Jarzembska; Philip Coppens
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-04-18

4.  Sensitivity of molecular docking to induced fit effects in influenza virus neuraminidase.

Authors:  Louise Birch; Christopher W Murray; Michael J Hartshorn; Ian J Tickle; Marcel L Verdonk
Journal:  J Comput Aided Mol Des       Date:  2002-12       Impact factor: 3.686

5.  Permeability enhancers dramatically increase zanamivir absolute bioavailability in rats: implications for an orally bioavailable influenza treatment.

Authors:  Eric H Holmes; Harikrishna Devalapally; Libin Li; Michael L Perdue; Gary K Ostrander
Journal:  PLoS One       Date:  2013-04-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.